JP2023541671A5 - - Google Patents
Info
- Publication number
- JP2023541671A5 JP2023541671A5 JP2023517699A JP2023517699A JP2023541671A5 JP 2023541671 A5 JP2023541671 A5 JP 2023541671A5 JP 2023517699 A JP2023517699 A JP 2023517699A JP 2023517699 A JP2023517699 A JP 2023517699A JP 2023541671 A5 JP2023541671 A5 JP 2023541671A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063079819P | 2020-09-17 | 2020-09-17 | |
| US63/079,819 | 2020-09-17 | ||
| PCT/US2021/045055 WO2022060487A1 (en) | 2020-09-17 | 2021-08-06 | Alpha-synuclein vaccine for the treatment of synucleinopathies |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023541671A JP2023541671A (ja) | 2023-10-03 |
| JPWO2022060487A5 JPWO2022060487A5 (https=) | 2024-08-14 |
| JP2023541671A5 true JP2023541671A5 (https=) | 2024-08-14 |
Family
ID=80777122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517699A Pending JP2023541671A (ja) | 2020-09-17 | 2021-08-06 | シヌクレイノパチーの処置のためのアルファ－シヌクレインワクチン |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230355756A1 (https=) |
| EP (1) | EP4213867A4 (https=) |
| JP (1) | JP2023541671A (https=) |
| KR (1) | KR20230087487A (https=) |
| CN (1) | CN116783211A (https=) |
| AR (1) | AR123189A1 (https=) |
| AU (1) | AU2021344230A1 (https=) |
| CA (1) | CA3192429A1 (https=) |
| IL (1) | IL301224A (https=) |
| MX (1) | MX2023003007A (https=) |
| TW (1) | TW202227465A (https=) |
| WO (1) | WO2022060487A1 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2025507875A (ja) | 2022-02-28 | 2025-03-21 | トライデム バイオサイエンス ゲーエムベーハー ウント コンパニー カーゲー | 少なくともβ－グルカン若しくはマンナンからなるか、又はこれを含む結合体 |
| WO2023161528A1 (en) | 2022-02-28 | 2023-08-31 | Tridem Bioscience Gmbh & Co Kg | A CONJUGATE COMPRISING AT LEAST A ß-GLUCAN |
| KR20260021636A (ko) | 2023-06-15 | 2026-02-13 | 쓰리엠 이노베이티브 프로퍼티즈 컴파니 | 프라이머 조성물, 접착 시스템, 및 관련 공정 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2657953A1 (en) * | 2005-07-19 | 2007-01-25 | University Of Rochester | Alpha-synuclein antibodies and methods related thereto |
| PL2118300T3 (pl) * | 2007-02-23 | 2015-11-30 | Prothena Biosciences Ltd | Zapobieganie i leczenie synukleinopatii i amyloidozy |
| US8147833B2 (en) * | 2007-02-23 | 2012-04-03 | Neotope Biosciences Limited | Prevention and treatment of synucleinopathic and amyloidogenic disease |
| HUE025225T2 (en) * | 2007-02-23 | 2016-02-29 | Prothena Biosciences Ltd | Prevention and treatment of synucleinopathic and amyloidogenic diseases |
| AU2008293504B2 (en) * | 2007-08-27 | 2012-04-12 | Longhorn Vaccines & Diagnostics, Llc | Immunogenic compositions and methods |
| CA2885924C (en) * | 2012-08-21 | 2022-12-13 | Institute For Molecular Medicine, Inc. | Compositions and methods related to diseases associated with deposits of amyloid, tau, and alpha-synuclein |
| AU2013344571A1 (en) * | 2012-11-16 | 2015-06-04 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Gonorrheal MtrE peptides and vaccines |
| CN110506057B (zh) * | 2017-02-17 | 2023-09-29 | 百时美施贵宝公司 | Alpha突触核蛋白抗体及其应用 |
| BR112019026707A2 (pt) * | 2017-06-16 | 2020-06-30 | United Neuroscience | imunógenos de peptídeo da extremidade c-terminal da proteína alfa-sinucleína e formulações dos mesmos para o tratamento de sinucleinopatias |
| WO2019070480A1 (en) * | 2017-10-02 | 2019-04-11 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | ASSAY FOR DETECTION OF ALPHA-SYNUCLEIN SELF-ACTIVATION ACTIVITY ASSOCIATED WITH SYNUCLEINOPATHIES |
| KR102710762B1 (ko) * | 2017-10-25 | 2024-09-25 | 얀센 파마슈티칼즈, 인코포레이티드 | 인산화 타우 펩티드의 조성물 및 이의 용도 |
| CN112368386A (zh) * | 2018-05-23 | 2021-02-12 | 磨石肿瘤生物技术公司 | 共有抗原 |
-
2021
- 2021-08-06 JP JP2023517699A patent/JP2023541671A/ja active Pending
- 2021-08-06 KR KR1020237012532A patent/KR20230087487A/ko active Pending
- 2021-08-06 WO PCT/US2021/045055 patent/WO2022060487A1/en not_active Ceased
- 2021-08-06 MX MX2023003007A patent/MX2023003007A/es unknown
- 2021-08-06 EP EP21869943.7A patent/EP4213867A4/en active Pending
- 2021-08-06 IL IL301224A patent/IL301224A/en unknown
- 2021-08-06 CA CA3192429A patent/CA3192429A1/en active Pending
- 2021-08-06 US US18/245,533 patent/US20230355756A1/en active Pending
- 2021-08-06 CN CN202180064031.1A patent/CN116783211A/zh active Pending
- 2021-08-06 AU AU2021344230A patent/AU2021344230A1/en active Pending
- 2021-08-09 AR ARP210102220A patent/AR123189A1/es unknown
- 2021-08-09 TW TW110129346A patent/TW202227465A/zh unknown